一种具有抗诱变活性的双机制抗菌肽靶向复制体并诱导细胞包膜应激。

IF 3.1 2区 生物学 Q2 MICROBIOLOGY
mSphere Pub Date : 2025-09-30 Epub Date: 2025-08-29 DOI:10.1128/msphere.00068-25
Amanda Holstad Singleton, Olaug Elisabeth Torheim Bergum, Jana Scheffold, Synnøve Brandt Ræder, Lilja Brekke Thorfinnsdottir, Lisa Marie Røst, Caroline Krogh Søgaard, Per Bruheim, Marit Otterlei
{"title":"一种具有抗诱变活性的双机制抗菌肽靶向复制体并诱导细胞包膜应激。","authors":"Amanda Holstad Singleton, Olaug Elisabeth Torheim Bergum, Jana Scheffold, Synnøve Brandt Ræder, Lilja Brekke Thorfinnsdottir, Lisa Marie Røst, Caroline Krogh Søgaard, Per Bruheim, Marit Otterlei","doi":"10.1128/msphere.00068-25","DOIUrl":null,"url":null,"abstract":"<p><p>To combat the growing threat of multidrug-resistant bacteria, we need to develop novel antibiotics with unique modes of action. This study investigates the antibacterial properties of BTP-001 toward <i>Escherichia coli</i>. BTP-001 targets the β-clamp subunit of the DNA Pol III holoenzyme and is composed of the binding motif APIM linked to a cell-penetrating part composed of 11 arginine residues (R11). Our data indicate that R11 facilitates energy-dependent transport of BTP-001 across the cell membrane, possibly via iron transport systems such as the TonB system. The full-length BTP-001 peptide rapidly disturbs membrane integrity, inducing expression and activation of the Cpx cell envelope stress response. This response likely triggers the production of reactive oxygen species (ROS), contributing to the rapid bactericidal effect, as evidenced by increased short-term survival by addition of a ROS scavenger. Furthermore, this study confirms that BTP-001 targets DNA replication and reduces resistance development by inhibiting translesion synthesis. In addition, our data suggest that the β-clamp is associated with ribosomal complexes and that BTP-001 disrupts translational processes. In conclusion, BTP-001 exhibits a multifaceted mode of action, which strengthens its potential as a novel therapeutic drug against antibiotic-resistant bacteria.IMPORTANCEAs antimicrobial resistance (AMR) increases, the world needs new antibiotics with new modes of action to avoid cross-resistance. In this study, we investigated how BTP-001, a novel cell-penetrating peptide that contains a protein-binding motif for the essential DNA replication protein β-clamp, kills bacteria. We demonstrate that BTP-001 has a dual mode of action in which it i) targets the β-clamp and inhibits replication and mutagenesis and ii) disrupts the bacterial cell envelope, causing ROS accumulation and rapid cell death. In addition, our data indicate that BTP-001 affects translation, suggesting that the β-clamp may have unknown roles beyond replication. Our data also suggest that the bacterial import of BTP-001, via the cell-penetrating part of the peptide, is dependent on active transport and involves iron uptake mechanisms. BTP-001 has many properties that could be useful for further development as a new antibiotic.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0006825"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482183/pdf/","citationCount":"0","resultStr":"{\"title\":\"A dual-mechanism antimicrobial peptide with antimutagenic activity targets the replisome and induces cell envelope stress.\",\"authors\":\"Amanda Holstad Singleton, Olaug Elisabeth Torheim Bergum, Jana Scheffold, Synnøve Brandt Ræder, Lilja Brekke Thorfinnsdottir, Lisa Marie Røst, Caroline Krogh Søgaard, Per Bruheim, Marit Otterlei\",\"doi\":\"10.1128/msphere.00068-25\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>To combat the growing threat of multidrug-resistant bacteria, we need to develop novel antibiotics with unique modes of action. This study investigates the antibacterial properties of BTP-001 toward <i>Escherichia coli</i>. BTP-001 targets the β-clamp subunit of the DNA Pol III holoenzyme and is composed of the binding motif APIM linked to a cell-penetrating part composed of 11 arginine residues (R11). Our data indicate that R11 facilitates energy-dependent transport of BTP-001 across the cell membrane, possibly via iron transport systems such as the TonB system. The full-length BTP-001 peptide rapidly disturbs membrane integrity, inducing expression and activation of the Cpx cell envelope stress response. This response likely triggers the production of reactive oxygen species (ROS), contributing to the rapid bactericidal effect, as evidenced by increased short-term survival by addition of a ROS scavenger. Furthermore, this study confirms that BTP-001 targets DNA replication and reduces resistance development by inhibiting translesion synthesis. In addition, our data suggest that the β-clamp is associated with ribosomal complexes and that BTP-001 disrupts translational processes. In conclusion, BTP-001 exhibits a multifaceted mode of action, which strengthens its potential as a novel therapeutic drug against antibiotic-resistant bacteria.IMPORTANCEAs antimicrobial resistance (AMR) increases, the world needs new antibiotics with new modes of action to avoid cross-resistance. In this study, we investigated how BTP-001, a novel cell-penetrating peptide that contains a protein-binding motif for the essential DNA replication protein β-clamp, kills bacteria. We demonstrate that BTP-001 has a dual mode of action in which it i) targets the β-clamp and inhibits replication and mutagenesis and ii) disrupts the bacterial cell envelope, causing ROS accumulation and rapid cell death. In addition, our data indicate that BTP-001 affects translation, suggesting that the β-clamp may have unknown roles beyond replication. Our data also suggest that the bacterial import of BTP-001, via the cell-penetrating part of the peptide, is dependent on active transport and involves iron uptake mechanisms. BTP-001 has many properties that could be useful for further development as a new antibiotic.</p>\",\"PeriodicalId\":19052,\"journal\":{\"name\":\"mSphere\",\"volume\":\" \",\"pages\":\"e0006825\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482183/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"mSphere\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1128/msphere.00068-25\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"mSphere","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1128/msphere.00068-25","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

为了对抗多重耐药细菌日益增长的威胁,我们需要开发具有独特作用模式的新型抗生素。研究了BTP-001对大肠杆菌的抑菌性能。BTP-001靶向DNA Pol III全酶的β-clamp亚基,由与11个精氨酸残基(R11)组成的细胞穿透部分连接的结合基序APIM组成。我们的数据表明,R11促进了BTP-001在细胞膜上的能量依赖性运输,可能是通过铁转运系统,如TonB系统。全长BTP-001肽迅速扰乱细胞膜完整性,诱导Cpx细胞包膜应激反应的表达和激活。这种反应可能会触发活性氧(ROS)的产生,有助于快速杀菌效果,添加ROS清除剂可以提高短期存活率。此外,本研究证实BTP-001通过抑制翻译合成靶向DNA复制并减少耐药性的产生。此外,我们的数据表明β-clamp与核糖体复合物有关,而BTP-001破坏了翻译过程。总之,BTP-001表现出多方面的作用模式,这加强了其作为抗抗生素耐药细菌的新型治疗药物的潜力。随着抗菌素耐药性(AMR)的增加,世界需要具有新作用模式的新抗生素来避免交叉耐药。在这项研究中,我们研究了BTP-001是一种新型的细胞穿透肽,它含有必要的DNA复制蛋白β-clamp的蛋白质结合基序,如何杀死细菌。我们证明了BTP-001具有双重作用模式,其中它i)靶向β-箝位并抑制复制和诱变,ii)破坏细菌细胞包膜,导致ROS积累和细胞快速死亡。此外,我们的数据表明BTP-001影响翻译,这表明β-clamp可能具有复制之外的未知作用。我们的数据还表明,细菌通过肽的细胞穿透部分输入BTP-001,依赖于主动转运并涉及铁摄取机制。BTP-001具有许多特性,可以作为一种新的抗生素进一步开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A dual-mechanism antimicrobial peptide with antimutagenic activity targets the replisome and induces cell envelope stress.

To combat the growing threat of multidrug-resistant bacteria, we need to develop novel antibiotics with unique modes of action. This study investigates the antibacterial properties of BTP-001 toward Escherichia coli. BTP-001 targets the β-clamp subunit of the DNA Pol III holoenzyme and is composed of the binding motif APIM linked to a cell-penetrating part composed of 11 arginine residues (R11). Our data indicate that R11 facilitates energy-dependent transport of BTP-001 across the cell membrane, possibly via iron transport systems such as the TonB system. The full-length BTP-001 peptide rapidly disturbs membrane integrity, inducing expression and activation of the Cpx cell envelope stress response. This response likely triggers the production of reactive oxygen species (ROS), contributing to the rapid bactericidal effect, as evidenced by increased short-term survival by addition of a ROS scavenger. Furthermore, this study confirms that BTP-001 targets DNA replication and reduces resistance development by inhibiting translesion synthesis. In addition, our data suggest that the β-clamp is associated with ribosomal complexes and that BTP-001 disrupts translational processes. In conclusion, BTP-001 exhibits a multifaceted mode of action, which strengthens its potential as a novel therapeutic drug against antibiotic-resistant bacteria.IMPORTANCEAs antimicrobial resistance (AMR) increases, the world needs new antibiotics with new modes of action to avoid cross-resistance. In this study, we investigated how BTP-001, a novel cell-penetrating peptide that contains a protein-binding motif for the essential DNA replication protein β-clamp, kills bacteria. We demonstrate that BTP-001 has a dual mode of action in which it i) targets the β-clamp and inhibits replication and mutagenesis and ii) disrupts the bacterial cell envelope, causing ROS accumulation and rapid cell death. In addition, our data indicate that BTP-001 affects translation, suggesting that the β-clamp may have unknown roles beyond replication. Our data also suggest that the bacterial import of BTP-001, via the cell-penetrating part of the peptide, is dependent on active transport and involves iron uptake mechanisms. BTP-001 has many properties that could be useful for further development as a new antibiotic.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
mSphere
mSphere Immunology and Microbiology-Microbiology
CiteScore
8.50
自引率
2.10%
发文量
192
审稿时长
11 weeks
期刊介绍: mSphere™ is a multi-disciplinary open-access journal that will focus on rapid publication of fundamental contributions to our understanding of microbiology. Its scope will reflect the immense range of fields within the microbial sciences, creating new opportunities for researchers to share findings that are transforming our understanding of human health and disease, ecosystems, neuroscience, agriculture, energy production, climate change, evolution, biogeochemical cycling, and food and drug production. Submissions will be encouraged of all high-quality work that makes fundamental contributions to our understanding of microbiology. mSphere™ will provide streamlined decisions, while carrying on ASM''s tradition for rigorous peer review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信